Author

André Serra‐Roma

Novartis (Switzerland)ORCID 0000-0001-7312-0589Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Ana Luísa MachadoiD· 1 shared Andreia RibeiroiD· 1 shared Flávia MartinsiD· 1 shared Joana CarvalhoiD· 1 shared María José OliveiraiD· 1 shared Patrícia Dias CarvalhoiD· 1 shared Patrícia OliveiraiD· 1 shared Sérgia VelhoiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Luísa MachadoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancersPeer-reviewedJul 20, 2024

Unveiling the Mechanisms to Bypass KRAS Inhibition: In Vitro Insights into the Influence of Fibroblast-Secretome

Susana Mendonça, Patrícia Dias Carvalho, André Serra‐Roma…·Sérgia Velho

This study investigates how fibroblast-secreted factors promote KRAS-independent stemness in KRAS-mutant CRC cells, revealing a mechanism by which the tumor microenvironment contributes to resistance to KRAS inhibition.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky